The rise in popularity of anti-obesity medications (AOMs), such as popular brand names Ozempic and Wegovy could see a shift ...
Hemak, president and CEO of the Wright Centers for Community Health and Graduate Medical Education, was named one of the 100 most powerful and influential female leaders in ...
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...
Long hours of screen time, continuous oscillatory eyeball movements, and a sedentary lifestyle while sitting for hours on a ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
Oprah Winfrey said taking weight-loss drugs, like Ozempic and Wegovy, helped her realize the truth about 'thin people.' ...
10h
GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...
A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...
The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback